Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

the CONTROL Study Investigators

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial'. Together they form a unique fingerprint.

Medicine & Life Sciences